{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:50:16Z","timestamp":1791345016987,"version":"4.3.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangzhou Municipal Science and Technology Project","award":["2024A03J0641"],"award-info":[{"award-number":["2024A03J0641"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01257-8","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:53:50Z","timestamp":1783443230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hypoxia-induced exosomal LNCOC1 orchestrates bladder cancer progression via the YBX1\/PIK3CA axis and serves as a potential liquid biopsy biomarker"],"prefix":"10.1007","volume":"49","author":[{"given":"Haoxiang","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangfeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"issue":"11","key":"1257_CR1","doi-asserted-by":"publisher","first-page":"e004128","DOI":"10.1136\/bmjgh-2020-004128","volume":"6","author":"S Safiri","year":"2021","unstructured":"S. Safiri, A.A. Kolahi, M. Naghavi, Global Burden of Disease Bladder Cancer Collaborators. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease study 2019. BMJ Glob Health. 6(11), e004128 (2021)","journal-title":"BMJ Glob Health"},{"issue":"3","key":"1257_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"F. Bray, M. Laversanne, H. Sung et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263 (2024)","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"1257_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","volume":"85","author":"J Alfred Witjes","year":"2024","unstructured":"J. Alfred Witjes, H. Max Bruins, A. Carri\u00f3n et al., European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines. Eur. Urol. 85(1), 17\u201331 (2024)","journal-title":"Eur. Urol."},{"key":"1257_CR4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.eururo.2017.03.019","volume":"73","author":"V Fonteyne","year":"2018","unstructured":"V. Fonteyne, P. Ost, J. Bellmunt et al., Curative Treatment for Muscle Invasive Bladder Cancer in Elderly Patients: A Systematic Review. Eur. Urol. 73, 40\u201350 (2018)","journal-title":"Eur. Urol."},{"issue":"19","key":"1257_CR5","first-page":"1980","volume":"324","author":"AT Lenis","year":"2020","unstructured":"A.T. Lenis, P.M. Lec, K. Chamie et al., Bladder Cancer: Rev. JAMA 324(19), 1980\u20131991 (2020)","journal-title":"Bladder Cancer: Rev. JAMA"},{"issue":"4","key":"1257_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/bjc.1955.55","volume":"9","author":"RH Thomlinson","year":"1955","unstructured":"R.H. Thomlinson, L.H. Gray, The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer. 9(4), 539\u2013549 (1955)","journal-title":"Br. J. Cancer"},{"issue":"2","key":"1257_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"P. Vaupel, A. Mayer, Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26(2), 225\u2013239 (2007)","journal-title":"Cancer Metastasis Rev."},{"issue":"7347","key":"1257_CR8","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10144","volume":"473","author":"P Carmeliet","year":"2011","unstructured":"P. Carmeliet, R.K. Jain, Molecular mechanisms and clinical applications of angiogenesis. Nature. 473(7347), 298\u2013307 (2011)","journal-title":"Nature"},{"issue":"2","key":"1257_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41590-020-00834-9","volume":"22","author":"NE Scharping","year":"2021","unstructured":"N.E. Scharping, D.B. Rivadeneira, A.V. Menk et al., Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion. Nat. Immunol. 22(2), 205\u2013215 (2021)","journal-title":"Nat. Immunol."},{"key":"1257_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41580-020-0227-y","volume":"21","author":"P Lee","year":"2020","unstructured":"P. Lee, N.S. Chandel, M.C. Simon, Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat. Rev. Mol. Cell. Biol. 21, 268\u2013283 (2020)","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"1257_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.pharmthera.2016.04.009","volume":"164","author":"C Wigerup","year":"2016","unstructured":"C. Wigerup, S. P\u00e5hlman, D. Bexell, Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer. Pharmacol. Ther. 164, 152\u2013169 (2016)","journal-title":"Pharmacol. Ther."},{"key":"1257_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nm0297-177","volume":"3","author":"G Helmlinger","year":"1997","unstructured":"G. Helmlinger, F. Yuan, M. Dellian, R.K. Jain, Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3, 177\u2013182 (1997)","journal-title":"Nat. Med."},{"key":"1257_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fcell.2019.00004","volume":"7","author":"W Al Tameemi","year":"2019","unstructured":"W. Al Tameemi, T.P. Dale, R.M.K. Al-Jumaily, N.R. Forsyth, Hypoxia-modified cancer cell metabolism. Front. Cell. Dev. Biol. 7, 4 (2019)","journal-title":"Front. Cell. Dev. Biol."},{"issue":"1","key":"1257_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-021-01440-5","volume":"21","author":"G He","year":"2022","unstructured":"G. He, X. Peng, S. Wei, S. Yang, X. Li, M. Huang, S. Tang, H. Jin, J. Liu, S. Zhang, H. Zheng, Q. Fan, J. Liu, L. Yang, H. Li, Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications. Mol. Cancer. 21(1), 19 (2022)","journal-title":"Mol. Cancer"},{"key":"1257_CR15","doi-asserted-by":"publisher","first-page":"7312","DOI":"10.1073\/pnas.1220998110","volume":"110","author":"P Kucharzewska","year":"2013","unstructured":"P. Kucharzewska, H.C. Christianson, J.E. Welch et al., Exosomes refect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development. Proc. Natl. Acad. Sci. U S A 110, 7312\u20137317 (2013)","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"1257_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-018-0823-z","volume":"17","author":"R Zhou","year":"2018","unstructured":"R. Zhou, K.K. Chen, J. Zhang et al., The decade of exosomal long RNA species: an emerging cancer antagonist. Mol. Cancer. 17(1), 75 (2018)","journal-title":"Mol. Cancer"},{"issue":"11","key":"1257_CR17","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00018-019-03018-3","volume":"76","author":"M Wang","year":"2019","unstructured":"M. Wang, L. Zhou, F. Yu et al., The functional roles of exosomal long non-coding RNAs in cancer. Cell. Mol. Life Sci. 76(11), 2059\u20132076 (2019)","journal-title":"Cell. Mol. Life Sci."},{"key":"1257_CR18","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.omto.2021.11.005","volume":"23","author":"Y Liu","year":"2021","unstructured":"Y. Liu, W. Ding, W. Yu et al., Long non-coding RNAs: Biogenesis, functions, and clinical significance in gastric cancer. Mol. Ther. Oncolytics. 23, 458\u2013476 (2021)","journal-title":"Mol. Ther. Oncolytics"},{"issue":"6","key":"1257_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"J.S. Mattick, P.P. Amaral, P. Carninci et al., Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat. Rev. Mol. Cell. Biol. 24(6), 430\u2013447 (2023)","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"3","key":"1257_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jgg.2018.03.001","volume":"45","author":"F Tao","year":"2018","unstructured":"F. Tao, X. Tian, M. Lu, Z. Zhang, A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c. J. Genet. Genomics. 45(3), 137\u2013145 (2018)","journal-title":"J. Genet. Genomics"},{"issue":"1","key":"1257_CR21","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"C. Th\u00e9ry, K.W. Witwer, E. Aikawa et al., Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 7(1), 1535750 (2018)","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"1257_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13046-020-01561-7","volume":"39","author":"K Hua","year":"2020","unstructured":"K. Hua, X. Deng, J. Hu, C. Ji, Y. Yu, J. Li, X. Wang, L. Fang, Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer. J. Exp. Clin. Cancer Res. 39(1), 58 (2020)","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"1257_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41467-020-20527-z","volume":"12","author":"B Li","year":"2021","unstructured":"B. Li, L. Zhu, C. Lu, C. Wang, H. Wang, H. Jin, X. Ma, Z. Cheng, C. Yu, S. Wang, Q. Zuo, Y. Zhou, J. Wang, C. Yang, Y. Lv, L. Jiang, W. Qin, circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat. Commun. 12(1), 295 (2021)","journal-title":"Nat. Commun."},{"issue":"1","key":"1257_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12943-020-01208-3","volume":"19","author":"M Xie","year":"2020","unstructured":"M. Xie, T. Yu, X. Jing, L. Ma, Y. Fan, F. Yang, P. Ma, H. Jiang, X. Wu, Y. Shu, T. Xu, Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p\/HUR\/VEGF axis and suppressing HSP90 degradation. Mol. Cancer. 19(1), 112 (2020)","journal-title":"Mol. Cancer"},{"issue":"W1","key":"1257_CR25","doi-asserted-by":"publisher","first-page":"W72","DOI":"10.1093\/nar\/gkab393","volume":"49","author":"A Armaos","year":"2021","unstructured":"A. Armaos, A. Colantoni, G. Proietti, J. Rupert, G.G. Tartaglia, catRAPID omics v2.0: going deeper and wider in the prediction of protein-RNA interactions. Nucleic Acids Res. 49(W1), W72\u2013W79 (2021)","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"1257_CR26","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41388-024-03237-4","volume":"44","author":"T Tang","year":"2025","unstructured":"T. Tang, T. Yang, H. Xue et al., Breast cancer stem cell-derived exosomal lnc-PDGFD induces fibroblast-niche formation and promotes lung metastasis. Oncogene. 44(9), 601\u2013617 (2025)","journal-title":"Oncogene"},{"issue":"1","key":"1257_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-024-01643-5","volume":"17","author":"H Fang","year":"2024","unstructured":"H. Fang, W. Dai, R. Gu et al., myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment. J. Hematol. Oncol. 17(1), 126 (2024)","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"1257_CR28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41388-024-03213-y","volume":"44","author":"W Ning","year":"2025","unstructured":"W. Ning, J. Yang, R. Ni et al., Hypoxia induced cellular and exosomal RPPH1 promotes breast cancer angiogenesis and metastasis through stabilizing the IGF2BP2\/FGFR2 axis. Oncogene. 44(3), 147\u2013164 (2025)","journal-title":"Oncogene"},{"issue":"6","key":"1257_CR29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","volume":"152","author":"PJ Batista","year":"2013","unstructured":"P.J. Batista, H.Y. Chang, Long noncoding RNAs: cellular address codes in development and disease. Cell. 152(6), 1298\u20131307 (2013)","journal-title":"Cell"},{"issue":"1","key":"1257_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","volume":"78","author":"M Corley","year":"2020","unstructured":"M. Corley, M.C. Burns, G.W. Yeo, How RNA-Binding Proteins Interact with RNA: Molecules and Mechanisms. Mol. Cell. 78(1), 9\u201329 (2020)","journal-title":"Mol. Cell."},{"issue":"D1","key":"1257_CR31","doi-asserted-by":"publisher","first-page":"D43","DOI":"10.1093\/nar\/gkw965","volume":"45","author":"KR Zhou","year":"2017","unstructured":"K.R. Zhou, S. Liu, W.J. Sun, L.L. Zheng, H. Zhou, J.H. Yang, L.H. Qu, ChIPBase v2.0: decoding transcriptional regulatory networks of non-coding RNAs and protein-coding genes from ChIP-seq data. Nucleic Acids Res. 45(D1), D43\u2013D50 (2017)","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"1257_CR32","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1515\/cclm-2023-0291","volume":"61","author":"N Wang","year":"2023","unstructured":"N. Wang, C. Yao, C. Luo, S. Liu, L. Wu, W. Hu, Q. Zhang, Y. Rong, C. Yuan, F. Wang, Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer. Clin. Chem. Lab. Med. 61(12), 2216\u20132228 (2023)","journal-title":"Clin. Chem. Lab. Med."},{"issue":"5","key":"1257_CR33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/bios12050287","volume":"12","author":"K Clack","year":"2022","unstructured":"K. Clack, N. Soda, S. Kasetsirikul, R. Kline, C. Salomon, M.J.A. Shiddiky, An Interfacial Affinity Interaction-Based Method for Detecting HOTAIR lncRNA in Cancer Plasma Samples. Biosens. (Basel). 12(5), 287 (2022)","journal-title":"Biosens. (Basel)"},{"issue":"1","key":"1257_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.7150\/thno.21945","volume":"8","author":"C He","year":"2018","unstructured":"C. He, S. Zheng, Y. Luo, B. Wang, Exosome Theranostics: biology and Translational Medicine. Theranostics. 8(1), 237\u2013255 (2018)","journal-title":"Theranostics"},{"key":"1257_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jconrel.2015.06.029","volume":"219","author":"L Milane","year":"2015","unstructured":"L. Milane, A. Singh, G. Mattheolabakis, M. Suresh, M.M. Amiji, Exosome mediated communication within the tumor microenvironment. J. Control Release. 219, 278\u2013294 (2015)","journal-title":"J. Control Release"},{"issue":"11","key":"1257_CR36","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1002\/ijc.32762","volume":"146","author":"Z Tang","year":"2020","unstructured":"Z. Tang, D. Li, S. Hou et al., The cancer exosomes: Clinical implications, applications and challenges. Int. J. Cancer. 146(11), 2946\u20132959 (2020)","journal-title":"Int. J. Cancer"},{"issue":"10","key":"1257_CR37","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1007\/s43032-020-00202-w","volume":"27","author":"Y Liu","year":"2020","unstructured":"Y. Liu, Y. Chang, Y.X. Cai, Inhibition of Lnc-OC1 Induced Cell Apoptosis and Decreased Cell Viability by Releasing miR-34a and Inhibiting PD-L1 in Endometrial Carcinoma. Reprod. Sci. 27(10), 1848\u20131856 (2020)","journal-title":"Reprod. Sci."},{"key":"1257_CR38","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2147\/CCID.S359786","volume":"15","author":"C Liu","year":"2022","unstructured":"C. Liu, X. Ding, C. Wei, Y. Pei, F. Meng, Y. Zhong, Y. Liu, LncRNA LNCOC1 is Upregulated in Melanoma and Serves as a Potential Regulatory Target of miR-124 to Suppress Cancer Cell Invasion and Migration. Clin. Cosmet. Investig Dermatol. 15, 751\u2013762 (2022)","journal-title":"Clin. Cosmet. Investig Dermatol."},{"issue":"3","key":"1257_CR39","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1007\/s13346-024-01653-3","volume":"15","author":"H Zeng","year":"2025","unstructured":"H. Zeng, X. Zeng, C. Wang et al., Combination therapy using Cel-CSO\/Taxol NPs for reversing drug resistance in breast cancer through inhibiting PI3K\/AKT\/NF-\u03baB\/HIF-1\u03b1 pathway. Drug Deliv Transl Res. 15(3), 992\u20131010 (2025)","journal-title":"Drug Deliv Transl Res."},{"issue":"Pt 3","key":"1257_CR40","doi-asserted-by":"publisher","first-page":"116620","DOI":"10.1016\/j.bcp.2024.116620","volume":"230","author":"W Liu","year":"2024","unstructured":"W. Liu, C. Dou, C. Zhang et al., PX-478 induces apoptosis in acute myeloid leukemia under hypoxia by inhibiting the PI3K\/AKT\/mTOR pathway through downregulation of GBE1. Biochem. Pharmacol. 230(Pt 3), 116620 (2024)","journal-title":"Biochem. Pharmacol."},{"key":"1257_CR41","doi-asserted-by":"publisher","first-page":"156022","DOI":"10.1016\/j.phymed.2024.156022","volume":"135","author":"B Chen","year":"2024","unstructured":"B. Chen, Q. Chen, M. Lu et al., Hypocrellin A against intrahepatic Cholangiocarcinoma via multi-target inhibition of the PI3K-AKT-mTOR, MAPK, and STAT3 signaling pathways. Phytomedicine. 135, 156022 (2024)","journal-title":"Phytomedicine"},{"key":"1257_CR42","doi-asserted-by":"publisher","first-page":"156218","DOI":"10.1016\/j.phymed.2024.156218","volume":"135","author":"Y Qin","year":"2024","unstructured":"Y. Qin, D. Zhang, C. Shangguan et al., Altingia chinensis petroleum ether extract suppresses NSCLC via induction of apoptosis, attenuation of EMT, and downregulation of PI3K\/Akt pathway. Phytomedicine. 135, 156218 (2024)","journal-title":"Phytomedicine"},{"issue":"12","key":"1257_CR43","doi-asserted-by":"publisher","first-page":"e2204819","DOI":"10.1002\/advs.202204819","volume":"10","author":"Y Tian","year":"2023","unstructured":"Y. Tian, Z.H. Chen, P. Wu et al., MIR497HG-Derived miR-195 and miR-497 Mediate Tamoxifen Resistance via PI3K\/AKT Signaling in Breast Cancer. Adv. Sci. (Weinh). 10(12), e2204819 (2023)","journal-title":"Adv. Sci. (Weinh)"},{"issue":"7","key":"1257_CR44","doi-asserted-by":"publisher","first-page":"e2305922","DOI":"10.1002\/advs.202305922","volume":"11","author":"X Zheng","year":"2024","unstructured":"X. Zheng, J. Chen, M. Deng et al., G3BP1 and SLU7 Jointly Promote Immune Evasion by Downregulating MHC-I via PI3K\/Akt Activation in Bladder Cancer. Adv. Sci. (Weinh). 11(7), e2305922 (2024)","journal-title":"Adv. Sci. (Weinh)"},{"issue":"2","key":"1257_CR45","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/jmbi.2001.5334","volume":"316","author":"CP Kloks","year":"2002","unstructured":"C.P. Kloks, C.A. Spronk, E. Lasonder et al., The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1. J. Mol. Biol. 316(2), 317\u2013326 (2002)","journal-title":"J. Mol. Biol."},{"issue":"2","key":"1257_CR46","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/leu.2012.185","volume":"27","author":"KS Bommert","year":"2013","unstructured":"K.S. Bommert, M. Effenberger, E. Leich et al., The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival. Leukemia. 27(2), 441\u2013450 (2013)","journal-title":"Leukemia"},{"issue":"2","key":"1257_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ijc.30075","volume":"139","author":"K Shinkai","year":"2016","unstructured":"K. Shinkai, K. Nakano, L. Cui et al., Nuclear expression of Y-box binding protein-1 is associated with poor prognosis in patients with pancreatic cancer and its knockdown inhibits tumor growth and metastasis in mice tumor models. Int. J. Cancer. 139(2), 433\u2013445 (2016)","journal-title":"Int. J. Cancer"},{"issue":"2","key":"1257_CR48","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41418-023-01247-5","volume":"31","author":"HT Liu","year":"2024","unstructured":"H.T. Liu, Z.X. Gao, F. Li et al., LncRNA LY6E-DT and its encoded metastatic-related protein play oncogenic roles via different pathways and promote breast cancer progression. Cell. Death Differ. 31(2), 188\u2013202 (2024)","journal-title":"Cell. Death Differ."},{"issue":"3","key":"1257_CR49","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s12276-024-01184-4","volume":"56","author":"X Liu","year":"2024","unstructured":"X. Liu, Q. Wei, C. Yang et al., RNA m5C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer. Exp. Mol. Med. 56(3), 600\u2013615 (2024)","journal-title":"Exp. Mol. Med."},{"key":"1257_CR50","doi-asserted-by":"publisher","first-page":"101059","DOI":"10.1016\/j.drup.2024.101059","volume":"73","author":"F Li","year":"2024","unstructured":"F. Li, H. Zhang, Y. Huang et al., Single-cell transcriptome analysis reveals the association between histone lactylation and cisplatin resistance in bladder cancer. Drug Resist. Updat. 73, 101059 (2024)","journal-title":"Drug Resist. Updat"},{"key":"1257_CR51","doi-asserted-by":"crossref","unstructured":"Z. Li, L. Chen, G. Zhang et al., Loss of MNX1 Sensitizes Tumors to Cytotoxic T Cells by Degradation of PD-L1 mRNA. Adv. Sci. (Weinh) 2025:e2403077","DOI":"10.1002\/advs.202403077"},{"key":"1257_CR52","doi-asserted-by":"crossref","unstructured":"L. Yu, Q. Guo, Y. Li et al., CHMP4C promotes pancreatic cancer progression by inhibiting necroptosis via the RIPK1\/RIPK3\/MLKL pathway. J. Adv. Res. 2025;S2090-1232(25)00058-X.","DOI":"10.1016\/j.jare.2025.01.040"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01257-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01257-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:58:57Z","timestamp":1791341937000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01257-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":52,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1257"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01257-8","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving human participants were performed in accordance with the Declaration of Helsinki. The study was approved by the Ethics Committee of the General Hospital of Southern Theater Command (No. NZLLKZ2025072). All animal experiments were conducted in accordance with relevant institutional and national guidelines and approved by the Institutional Animal Care and Use Committee of the General Hospital of Southern Theater Command (No. NBZQZYY2025017).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"132"}}